Product Pathways - Adhesion
E-Cadherin Antibody #4065
| Applications | Reactivity | Sensitivity | MW (kDa) | Source |
|---|---|---|---|---|
| W IP IHC-P IF-IC | H M (B) (Dg) | Endogenous | 135 | Rabbit |
Applications Key:
W=Western Blotting
IP=Immunoprecipitation
IHC-P=Immunohistochemistry (Paraffin)
IF-IC=Immunofluorescence (Immunocytochemistry)
Reactivity Key:
H=Human
M=Mouse
B=Bovine
Dg=Dog
Species cross-reactivity is determined by Western blot.
Protocols
Specificity / Sensitivity
E-Cadherin Antibody detects endogenous levels of total E-Cadherin protein. The antibody does not cross-react with related family members, such as N-Cadherin.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to the sequence surrounding residue 780 of human E-Cadherin. Antibodies are purified by protein A and peptide affinity chromatography.
Western Blotting
Western blot analysis of extracts from A431, MCF-7 and C2C12 cells, using E-Cadherin Antibody. Note the absence of signal from C2C12 cells, which express N-cadherin instead of E-cadherin.
IHC-P (paraffin)
Immunohistochemical analysis of paraffin-embedded MCF-7 cells, showing membrane localization, using E-Cadherin Antibody.
IHC-P (paraffin)
Immunohistochemical analysis of paraffin-embedded human colon carcinoma, using E-Cadherin Antibody.
IHC-P (paraffin)
Immunohistochemical analysis of paraffin-embedded human squamous cell carcinoma of the lung, showing membrane localization, using E-Cadherin Antibody.
IHC-P (paraffin)
Immunohistochemical analysis of paraffin-embedded human breast fibroadenoma, using E-Cadherin Antibody in the presence of control peptide (left) or E-Cadherin Blocking Peptide #1056 (right).
IF-IC
Confocal immunofluorescent images of MCF-7 cells labeled with E-Cadherin Antibody (green, left) compared to an isotype control (right). Blue pseudocolor = DRAQ5™ (fluorescent DNA dye).See notes for additional testing details.
Background
Cadherins are a superfamily of transmembrane glycoproteins that contain cadherin repeats of approximately 100 residues in their extracellular domain. Cadherins mediate calcium-dependent cell-cell adhesion and play critical roles in normal tissue development (1). The classic cadherin subfamily includes N-, P-, R-, B- and E-cadherins as well as about ten other members which are found in adherens junctions (AJ), a cellular structure near the apical surface of polarized epithelial cells. The cytoplasmic domain of classical cadherins interacts with β-catenin, γ-catenin (also called plakoglobin) and p120 catenin. β-catenin and γ-catenin associate with α-catenin, which links the cadherin-catenin complex to the actin cytoskeleton (1,2). Unlike β- and γ-catenin, p120 regulates cadherin adhesive activity and trafficking rather than having a structural role in the junctional complex (1-4). E-cadherin is considered an active suppressor of invasion and growth of many epithelial cancers (1-3). Recent studies indicate that cancer cells have up-regulated N-cadherin in addition to loss of E-cadherin. This change in cadherin expression is called the "cadherin switch." N-Cadherin cooperates with the FGF receptor, leading to over-expression of MMP-9 and cellular invasion (3). In endothelial cells, VE-cadherin signaling, expression and localization are correlated with vascular permeability and tumor angiogenesis (5,6). Expression of P-cadherin, which is normally present in epithelial cells, is also altered in ovarian and other human cancers (7,8).
- Wheelock, M.J. and Johnson, K.R. (2003) Annu. Rev. Cell. Dev. Biol. 19, 207-235.
- Christofori, G. (2003) EMBO J. 22, 2318-2323.
- Hazan, R.B. et al. (2004) Ann. NY Acad. Sci. 1014, 155-163.
- Bryant, D.M. and Stow, J.L. (2004) Trends Cell Biol. 14, 427-434.
- Rabascio, C. et al. (2004) Cancer Res. 64, 4373-4377.
- Yamaoka-Tojo, M. et al. (2006) Arterioscler. Thromb. Vasc. Biol. 26, 1991-1997.
- Patel, I.S. et al. (2003) Int. J. Cancer 106, 172-177.
- Sanders, D.S. et al. (2000) J. Pathol. 190, 526-530.
Application References
- Chen, Y. et al. (2007) Mol Cell Proteomics 6, 2072-87. Applications: IP Western Blotting
- Shan, B. et al. (2008) J Biol Chem 283, 21065-73. Applications: Western Blotting
- Dougherty, S.M. et al. (2006) Endocr Relat Cancer 13, 113-34. Applications: Western Blotting
- Wang, J. et al. (2009) J Histochem Cytochem 57, 363-71. Applications: IHC-P (paraffin)
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
Companion Products
- 9562 β-Catenin Antibody
- 9561 Phospho-β-Catenin (Ser33/37/Thr41) Antibody
- 9564 Phospho-β-Catenin (Ser45) Antibody
- 9565 Phospho-β-Catenin (Thr41/Ser45) Antibody
- 7071 Phototope®-HRP Western Blot Detection System, Anti-rabbit IgG, HRP-linked Antibody
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 7727 Biotinylated Protein Ladder Detection Pack
- 7003 20X LumiGLO® Reagent and 20X Peroxide
- 1056 E-Cadherin Blocking Peptide
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.